Clinical Trials Logo

Clinical Trial Summary

The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.


Clinical Trial Description

This is a retrospective/prospective, multi-site observational study, designed to evaluate the clinical outcomes and complication rates in subjects who were previously implanted with a Fibulock™ intramedullary nail. Patients will be screened for eligibility and subgroupings. Informed consent will be obtained from those who meet screening criteria and are interested in participating in the study. Sites will be asked to enroll subjects according to past treatment, with the Fibulock™ intramedullary nail for unstable fibula fracture. The sites will enroll subjects in the study based on inclusion/exclusion criteria. Patient pre-operative, intra-operative and post-operative records will be reviewed retrospectively. Once enrolled, subjects will undergo an evaluation of fracture outcome and complete a VAS pain score, SF-12, and Foot Function Index at 26 weeks and again at 52 weeks post-treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02688296
Study type Observational
Source Arthrex, Inc.
Contact
Status Completed
Phase
Start date May 24, 2016
Completion date July 9, 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT05317676 - Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation Phase 2
Enrolling by invitation NCT04872296 - Weight Bearing for Fibular Fractures N/A
Recruiting NCT05445960 - Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery N/A